Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The device identifies the biomarker molecule CA19-9, which is associated with the disease, at low concentrations in a patient’s blood. This offers a simpler, more affordable alternative to conventional tests, which are less accessible. A paper describing this work appears in ACS Omega.
This article was originally published on MedicalXpress.com
In this article, we will introduce you to 12 incredibly effective foot massage techniques that will leave you feeling rejuvenated and relaxed. Foot massages aren’t just a luxury; they provide numerous health benefits, such as […]
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
© 2025 SimplyWell.ca